|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0150 CAD | 0.00% |
|
0.00% | -75.00% |
| 04-02 | RAMM Pharma Corp. Reports Earnings Results for the First Quarter Ended January 31, 2026 | CI |
| 03-05 | RAMM Pharma Corp. Reports Earnings Results for the Full Year Ended October 31, 2025 | CI |
| Market Cap | 1.79M 1.28M 1.11M 1.02M 956K 122M 1.82M 12.05M 4.7M 59.34M 4.81M 4.71M 205M | P/E Ratio 2024 |
-0.07x | P/E Ratio 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.07M 764K 660K 608K 570K 72.66M 1.08M 7.18M 2.8M 35.37M 2.87M 2.81M 122M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 6 months | -40.00% | ||
| Current year | -75.00% |
| 1 month | 0.01 | 0.02 | |
| Current year | 0.01 | 0.05 | |
| 1 year | 0.01 | 0.25 | |
| 3 years | 0 | 0.25 | |
| 5 years | 0 | 1 | |
| 10 years | 0 | 1.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 2019-09-30 |
José Roldan
DFI | Director of Finance/CFO | - | 2022-12-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 2019-09-30 |
Daniel Augereau
BRD | Director/Board Member | 82 | 2019-09-30 |
Eric Klein
BRD | Director/Board Member | 66 | 2019-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-06-01 | Sell | Chief Executive Officer | 4,667,000 | 3.9091% | ||
| 25-03-20 | Buy | Chief Executive Officer | 100,000 | 0.0838% | ||
| 25-03-20 | Buy | Chief Executive Officer | 200,000 | 0.1675% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | +50.00% | -70.00% | 1.28M | ||
| -2.41% | +0.14% | +38.28% | +154.20% | 1,010B | ||
| +1.07% | +3.48% | +53.32% | +49.85% | 580B | ||
| +1.32% | +0.22% | +19.18% | +64.65% | 402B | ||
| +0.77% | 0.00% | +21.28% | +16.70% | 330B | ||
| +0.44% | +3.48% | +25.65% | +35.66% | 281B | ||
| -0.85% | -2.86% | +22.54% | +14.67% | 280B | ||
| +1.66% | +1.20% | -44.35% | -47.35% | 197B | ||
| +0.32% | +1.61% | +20.32% | +60.01% | 192B | ||
| -0.22% | -2.76% | +14.19% | +60.09% | 156B | ||
| Average | +0.21% | +0.76% | +22.04% | +33.85% | 342.89B | |
| Weighted average by Cap. | -0.23% | +1.04% | +27.77% | +70.54% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.34M 3.11M 2.69M 2.48M 2.32M 296M 4.41M 29.23M 11.39M 144M 11.67M 11.42M 498M | 3.36M 2.41M 2.08M 1.92M 1.79M 229M 3.41M 22.62M 8.82M 111M 9.03M 8.84M 386M |
| Net income | -16.5M -11.82M -10.21M -9.41M -8.81M -1.12B -16.76M -111M -43.31M -547M -44.36M -43.41M -1.89B | -8.91M -6.38M -5.51M -5.08M -4.75M -607M -9.05M -59.97M -23.38M -295M -23.95M -23.44M -1.02B |
| Net Debt | -626K -448K -387K -357K -334K -42.6M -635K -4.21M -1.64M -20.73M -1.68M -1.65M -71.79M | -723K -518K -448K -412K -386K -49.25M -735K -4.87M -1.9M -23.97M -1.94M -1.9M -83.01M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- RAMM Stock
Select your edition
All financial news and data tailored to specific country editions
















